Axillary Dissection for Breast Cancer

University of Miami, Miami, FL
Breast CancerAxillary Dissection - Procedure
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a less invasive way of removing lymph nodes from people with breast cancer is just as effective as the standard method.

Eligible Conditions
  • Breast Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Up to 3 weeks

Day 1
Clipped Lymph Node Identification Rate
Sentinel Lymph Node Identification Rate
Up to 2 weeks
Accuracy Rate of Imaging Studies
False Negative Rate
Pathologic Complete Response (pCR)
Up to 3 weeks
Incidence of Treatment-Emergent Adverse Events

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Targeted Axillary Dissection (TAD)
1 of 1

Experimental Treatment

45 Total Participants · 1 Treatment Group

Primary Treatment: Axillary Dissection · No Placebo Group · N/A

Targeted Axillary Dissection (TAD)
Experimental Group · 1 Intervention: Axillary Dissection · Intervention Types: Procedure
First Studied
Drug Approval Stage
How many patients have taken this drug
Axillary Dissection

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 weeks

Who is running the clinical trial?

University of MiamiLead Sponsor
818 Previous Clinical Trials
388,966 Total Patients Enrolled
15 Trials studying Breast Cancer
1,500 Patients Enrolled for Breast Cancer
Susan Kesmodel, MDPrincipal InvestigatorUniversity of Miami
1 Previous Clinical Trials
5 Total Patients Enrolled
1 Trials studying Breast Cancer
5 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The researchers will check if you have cancer that has spread to nearby lymph nodes through physical examination and medical imaging tests.
You are a candidate for surgery to treat breast cancer.

Frequently Asked Questions

Does this trial offer opportunities to participate at the moment?

" states that this research study is actively seeking participants, which was first publicised on March 1st 2022 and recently modified on the 23rd of the same month." - Anonymous Online Contributor

Unverified Answer

What is the sample size of participants for this research project?

"That is correct. According to, this medical trial was posted on the 1st of March 2022 and has since been re-opened for recruitment with an update occurring on the 23rd of March. 45 candidates are being sought at one particular site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.